Market Overview:
The global levobupivacaine hydrochloride market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for levobupivacaine hydrochloride in various applications such as surgical epidural block and other applications. Levobupivacaine hydrochloride is a drug used for local anaesthesia and belongs to the class of amides. It is available as an injectable solution or infusion, and has a rapid onset of action with long duration of effect.
Product Definition:
Levobupivacaine Hydrochloride is a local anesthetic agent that is used to provide pain relief. It works by blocking nerve impulses from the area that has been injected. This can help to reduce pain, inflammation, and swelling.
99% Purity:
99% purity is a highly potent form of the generic drug Levobupivacaine Hydrochloride (LAH). It has been used as an active ingredient in various pharmaceutical products such as topical ointments, tablets, and injections. LAH is also marketed under different brand names such as Drowsiness Plus, Drowsol Robaxal, and Somnifilm among others.
Other:
Other refers to the non-opioid analgesic drugs that are used for pain relief. The other analgesics include gepants,ramelteon, and bupivacaine. Other drugs that contain levobupivacaine hydrochloride as an active ingredient are sold under various brand names such as Dont Forget Daquan, Donjoy, and generic brands like Nubain and Nucynta.
Application Insights:
Based on the application, the global levobupivacaine hydrochloride market is segmented into surgical epidural block and other applications. The other applications include dental surgery, gynecology and obstetrics procedures, pain management procedures (other than chronic pain), urology surgeries (kidney stone treatment), and others. Levobupivacaine hydrochloride is used for various types of pains including neurogenic pain, arthritis/osteoarthritis/rheumatoid arthritis type pains as well as low backache type pains. It is also used for chronic pelvic or lower back pain due to conditions such as herniated disc or spinal stenosis.
Regional Analysis:
North America dominated the global levobupivacaine hydrochloride market in 2017. The rising incidence of back pain and increasing use of this drug for chronic pain are some factors responsible for its largest revenue share. In addition, favorable reimbursement policies and high awareness levels about its benefits are also expected to drive growth during the forecast period.
Asia Pacific is anticipated to be one of the fastest-growing regions owing to various initiatives taken by governments in developing countries such as China and India aimed at reducing suffering from chronic diseases through improved healthcare facilities & infrastructure coupled with growing medical tourism industry. These factors are expected to boost demand for local anesthetics that include levobupivacaine hydrochloride over the forecast period.
Growth Factors:
- Increasing demand for regional anesthesia and better patient outcomes
- Growing number of ambulatory surgical centers (ASC) and outpatient procedures
- Rising incidence of pain disorders and chronic pain conditions
- Technological advancements in drug delivery systems
- Availability of generic versions of the drug
Scope Of The Report
Report Attributes
Report Details
Report Title
Levobupivacaine Hydrochloride Market Research Report
By Type
99% Purity, Other
By Application
Surgical Epidural Block, Other
By Companies
Rundu Pharma, Dishman Carbogen Amcis, Recipharm, Shanghai OSD, Nanjin Yihua, ASK Pharm, Jiangsu Hengrui Medicine
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Levobupivacaine Hydrochloride Market Report Segments:
The global Levobupivacaine Hydrochloride market is segmented on the basis of:
Types
99% Purity, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgical Epidural Block, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Rundu Pharma
- Dishman Carbogen Amcis
- Recipharm
- Shanghai OSD
- Nanjin Yihua
- ASK Pharm
- Jiangsu Hengrui Medicine
Highlights of The Levobupivacaine Hydrochloride Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99% Purity
- Other
- By Application:
- Surgical Epidural Block
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Levobupivacaine Hydrochloride Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Levobupivacaine hydrochloride is a medication used to relieve pain. It is an opioid and belongs to the class of drugs known as bupivacaine. Levobupivacaine hydrochloride is available in tablet form and as a cream for topical use.
Some of the major companies in the levobupivacaine hydrochloride market are Rundu Pharma, Dishman Carbogen Amcis, Recipharm, Shanghai OSD, Nanjin Yihua, ASK Pharm, Jiangsu Hengrui Medicine.
The levobupivacaine hydrochloride market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Levobupivacaine Hydrochloride Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Levobupivacaine Hydrochloride Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Levobupivacaine Hydrochloride Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Levobupivacaine Hydrochloride Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Levobupivacaine Hydrochloride Market Size & Forecast, 2020-2028
4.5.1 Levobupivacaine Hydrochloride Market Size and Y-o-Y Growth
4.5.2 Levobupivacaine Hydrochloride Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 99% Purity
5.2.2 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Surgical Epidural Block
6.2.2 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Levobupivacaine Hydrochloride Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Levobupivacaine Hydrochloride Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 99% Purity
9.6.2 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Surgical Epidural Block
9.10.2 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 99% Purity
10.6.2 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Surgical Epidural Block
10.10.2 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 99% Purity
11.6.2 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Surgical Epidural Block
11.10.2 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 99% Purity
12.6.2 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Surgical Epidural Block
12.10.2 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 99% Purity
13.6.2 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Surgical Epidural Block
13.10.2 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Levobupivacaine Hydrochloride Market: Competitive Dashboard
14.2 Global Levobupivacaine Hydrochloride Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Rundu Pharma
14.3.2 Dishman Carbogen Amcis
14.3.3 Recipharm
14.3.4 Shanghai OSD
14.3.5 Nanjin Yihua
14.3.6 ASK Pharm
14.3.7 Jiangsu Hengrui Medicine
